The Partnership for Safe Medicines India is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from spurious or contraband medicines. For more information, please visit jagograhakjago.com
    "Only switch medications under the supervision of a doctor or pharmacist” --Mr. Bejon Misra (Founder, PSM India) “Never buy medicines from illicit pharmacies or unknown sources” Biggest ever Global crackdown on illicit online pharmacies and fake drugs
article shared by Ms. Aline Plancon, INTERPOL enforcement officer and Head , Interpol Medical products counterfeiting and Pharmaceutical Crime Unit LYON, France: A global operation spanning 100 countries aimed at disrupting the organized crime networks behind the illicit online sale of medicines has resulted in some 80 arrests and the worldwide seizure of 3.75 million units of potentially life-threatening medicines worth USD 10.5 million. To view video , Click Here
 |
 Now manufacturing licences in generic names only
NEW DELHIi : Ministry of Health & Family Welfare, GOI, New Delhi has directed the Principal/Health Secretaries of all States/ Union Territories letter dated 1st Oct, 2012 under Section 33 (P) to to instruct respective licensing authorities to grant/renew manufacturing license of drug formulations in proper/generic name only.
 State FDA seizes drugs worth Rs.113-cr for violating Drugs & Magic Remedies Act
MUMBAI : The Maharashtra Food and Drugs Administration (FDA) has seized medical products worth around Rs.113 crores across the state during the last one year for violating the provisions of Drugs & Magic Remedies (Objectionable Advertisement) Act 1954. The Act is being enforced to curb the misleading ads with excessive claims of drugs in media like print, electronic, hoardings, in trains, etc.  Leading Health Care, Law Enforcement and Government Officials Join with Industry and Patient Advocates to Assess State of Counterfeit Medicines
FDA Withdraws Approval of Generic Antidepressant
The antidepressant Budeprion XL 300 mg, one of the generic formulations of extended-release bupropion hydrochloride, is not therapeutically equivalent to Wellbutrin XL 300 mg, the brand-name extended-release formulation, and will be removed from the market by the drug's manufacturers, according to an update from the US Food and Drug Administration (FDA).  Health ministry plans revision of Sch P to include new drugs currently marketed
NEW DELHI :The union health ministry may go in for a revision of the Schedule P of the Drugs and Cosmetics (D&C) Act in view of the changes in the pharmaceutical industry in recent times and to include new drugs which had been permitted for manufacturing and marketing in the country. Rajasthan's free medicine scheme benefits 200,000 people daily
JAIPUR : The free medicine scheme launched by Chief Minister Ashok Gehlot a year ago on Mahatma Gandhi's birth anniversary Oct 2 has seen a footfall of 70 million people at the distribution centres, officials said Sunday. |
WASHINGTON, D.C.: The Partnership for Safe Medicines (PSM) convened leading domestic and international stakeholders in the fight against counterfeit and substandard medicines, making a renewed commitment to work together and implement new solutions to protect patients worldwide. U.S. Food and Drug Administration Commissioner Dr. Margaret Hamburg, in a keynote to the conference, highlighted new efforts her agency is undertaking to reduce the threat and pledged the FDA’s ongoing support to ensure a safe U.S. drug supply.
“Human rights aren’t just about violence and terrorism. Unsafe drugs too fall into the category. The National Human Rights Commission (NHRC) has described the manufacture, distribution and sale of unsafe drugs and medical devices as a violation of human rights.”
Send in your news contribution and valuable feedback to THE EDITOR at
pooja@jagograhakjago.com
